NIH Guide: Weekly Index for December 4, 2020

Funding Opportunities

• NEI Institutional Mentored Physician Scientist Award (K12 Clinical Trial Optional)
  (PAR-21-073)
  National Eye Institute
  Application Receipt Date(s): June 9, 2021; June 9, 2022; June 9, 2023 All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s). Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
• NHLBI Program Project Applications (P01 Clinical Trials Optional)
  (PAR-21-088)
  National Heart, Lung, and Blood Institute
  Application Receipt Date(s): Standard dates apply. The first standard due date for this FOA is January 25, 2021. All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
• Limited Competition: Small Grant Program for ORIP Special Emphasis Research Career Award (SERCA) K01 Recipients (R03 Clinical Trials Not Allowed)
  (PAR-21-090)
  Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs
  Application Receipt Date(s): February 16, 2021; February 16, 2022; and February 16, 2023.
• Development of Innovative Informatics Methods and Algorithms for Cancer Research and Management (R21 Clinical Trial Optional)
  (RFA-CA-21-013)
  National Cancer Institute
  Application Receipt Date(s): June 8, 2021; November 17, 2021 No late applications will be accepted for this Funding Opportunity Announcement.
• Early-Stage Development of Informatics Technologies for Cancer Research and Management (U01 Clinical Trial Optional)
  (RFA-CA-21-014)
  National Cancer Institute
  Application Receipt Date(s): June 8, 2021; November 17, 2021 No late applications will be accepted for this Funding Opportunity Announcement.
• Advanced Development of Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional)
  (RFA-CA-21-015)
  National Cancer Institute
  Application Receipt Date(s): June 08, 2021; November 17, 2021 No late applications will be accepted for this Funding Opportunity Announcement.
• Sustained Support for Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional)
  (RFA-CA-21-016)
  National Cancer Institute
  Application Receipt Date(s): June 08, 2021; November 17, 2021 No late applications will be accepted for this Funding Opportunity Announcement.
• Revision Applications to Support the Application of Informatics Technology for Cancer Research (R01 Clinical Trials Optional)
  (RFA-CA-21-017)
  National Cancer Institute
  Application Receipt Date(s): June 08, 2021; November 17, 2021 No late applications will be accepted for this Funding Opportunity Announcement.
• Revision Applications to Support the Application of Informatics Technology for Cancer Research (U01 Clinical Trials Optional)
  (RFA-CA-21-018)
  National Cancer Institute
  Application Receipt Date(s): June 08, 2021; November 17, 2021 No late applications will be accepted for this Funding Opportunity Announcement.
• Revision Applications to Support the Application of Informatics Technology for Cancer Research (U24 Clinical Trial Optional)
  (RFA-CA-21-019)
  National Cancer Institute
  Application Receipt Date(s): June 09, 2021; November 18, 2021 No late applications will be accepted for this Funding Opportunity Announcement.
• Renewal - Cooperative Agreement to Support Shellfish Assistance Project (U01) Clinical Trial Not Allowed
  (RFA-FD-21-006)
  Food and Drug Administration
  Application Receipt Date(s): February 1, 2021 by 11:59 PM Eastern Time. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. Applicants should be aware that on-time submission means that an application is submitted error free (of both Grants.gov and eRA Commons errors) by 11:59 PM Eastern Time on the application due date. Late applications will not be accepted for this FOA.
• Renewal - Federal and University Partnership to Improve the Safety of Seafood from the Gulf of Mexico (U19 Clinical Trials Not Allowed)
  (RFA-FD-21-009)
  Food and Drug Administration
  Application Receipt Date(s): February 1, 2021 by 11:59 PM Eastern Time. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. Applicants should be aware that on-time submission means that an application is submitted error free (of both Grants.gov and eRA Commons errors) by 11:59 PM Eastern Time on the application due date. Late applications will not be accepted for this FOA.
• Summer Institute for Research Education in Biostatistics and Data Science (R25 Clinical Trial Not Allowed)
  (RFA-HL-22-009)
  National Heart, Lung, and Blood Institute
  National Institute of Allergy and Infectious Diseases
  Application Receipt Date(s): March 8, 2021